| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/03/2000 | CN1052010C Benzimidazole derivatives, preparation and use thereof and medicines containing same |
| 05/02/2000 | US6057301 Moisture resistant, improved storage stability |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | CA2287645A1 Process for producing nucleic acid derivatives |
| 05/02/2000 | CA2137176C Liponucleotide compounds |
| 05/02/2000 | CA2090024C Phospholipid derivatives of nucleosides, their preparation, as well as their use as anti-viral medicaments |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023456A1 Functionalized pyrimidine derivatives |
| 04/27/2000 | WO2000023455A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/27/2000 | WO2000023454A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection |
| 04/27/2000 | WO2000023447A1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties |
| 04/27/2000 | CA2315104A1 Functionalized pyrimidine derivatives |
| 04/26/2000 | EP0994890A2 Benzimidazole derivatives |
| 04/26/2000 | EP0994715A1 Difluoronucleoside phosphonic acids and derivatives thereof |
| 04/26/2000 | EP0973938A4 The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites |
| 04/26/2000 | EP0626853B1 Use of substituted adenine derivatives for treating multiple sclerosis |
| 04/26/2000 | CN1251521A Compound and method for therapeutic intervention in preventing diabetic complications |
| 04/25/2000 | US6054568 Polymer of nucleobases capable of watson/crick basepairing connected together by linkers and having terminating groups; for nucleic acid analogs which may be used in annealing, ligation, sequencing, cleavage and primer extension reactions |
| 04/25/2000 | US6054442 Methods and compositions for modulation and inhibition of telomerase in vitro |
| 04/25/2000 | US6054441 Antiinflammatory agents; treatment of bacterial, viral or fungal infections; autoimmune diseases |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/25/2000 | CA2110386C Method for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides |
| 04/25/2000 | CA2015671C Phosphonomethoxytetrahydrofuranyl-purine/pyrimidine derivatives |
| 04/20/2000 | WO2000022157A1 Non-homogeneous systems for the resolution of enantiomeric mixtures |
| 04/20/2000 | WO2000021974A1 Nucleotide compounds including a rigid linker |
| 04/20/2000 | WO2000021967A1 Functionalized silicon compounds, their synthesis and use |
| 04/20/2000 | WO2000004866A3 Preparation of thioarabinofuranosyl compounds and use thereof |
| 04/19/2000 | EP0785941B1 Porphyrin labeling of polynucleotides |
| 04/19/2000 | EP0586520B1 Backbone modified oligonucleotide analogs |
| 04/18/2000 | US6051719 Dibenzorhodamine dyes |
| 04/18/2000 | CA2182578C Halogenated derivatives of 2,3'-o-cyclocytidine compounds and process for production thereof |
| 04/18/2000 | CA1340961C 2', 3' - dideoxy - 2' - fluoronucleosides |
| 04/16/2000 | CA2252144A1 Dual action anticancer prodrugs |
| 04/13/2000 | WO2000020430A1 Crystal of diuridine tetraphosphate or salt thereof and method for preparing the same, and method for producing said compound |
| 04/13/2000 | WO2000020429A1 3',5'-cyclic phosphate compounds and methods thereof |
| 04/13/2000 | WO2000020428A2 Synthesis of oligosaccharides, reagents and methods related thereto |
| 04/13/2000 | CA2346237A1 Synthesis of oligosaccharides, reagents and methods related thereto |
| 04/12/2000 | EP0992510A1 N6 heterocyclic substituted adenosine derivatives |
| 04/12/2000 | EP0991412A1 Aminoacyl sulfamides for the treatment of hyperproliferative disorders |
| 04/12/2000 | EP0804414A4 Complementary dna and toxins |
| 04/12/2000 | CN1250369A Method of treating dry eye disease with purinergic receptor agonists |
| 04/11/2000 | US6048975 Use of dansylethoxycarbonyl group as base-labile 5'-hydroxyl protective group; ease of detection and ease of elimination with by-product inhibition for high yield synthesis in very small quantities |
| 04/11/2000 | CA2120725C Chemical compounds |
| 04/11/2000 | CA1340957C Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
| 04/06/2000 | WO2000018967A1 A method for analyzing polynucleotides |
| 04/06/2000 | WO2000018780A1 Nucleoside modifications by palladium catalyzed methods |
| 04/05/2000 | EP0990651A1 Process for producing 5-trifluoromethyluracil derivatives |
| 04/05/2000 | EP0989991A1 Purification of oligomers |
| 04/05/2000 | EP0989990A1 Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | CN1050996C Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine |
| 04/04/2000 | US6046322 Reduced temperature crystallization process for improved quality and large-scale production |
| 04/04/2000 | US6046313 Process for making morphine-6-glucuronide or substituted morphine-6-glucuronide |
| 04/04/2000 | US6046047 Genetic construct encoding a chimeric protein with a domain which binds and crosslinks a synthetic, membrane permeable, non-peptide ligand and domain to cause cellular localization of complex; for gene therapy and inducible gene expression |
| 04/04/2000 | CA2246162C Modulation of th1/th2 cytokine expression by ribavirin.rtm. and ribavirin.rtm. analogs in activated t-lymphocytes |
| 04/04/2000 | CA2204739C Macrocyclic lactone compounds and their production process |
| 03/30/2000 | WO2000016625A1 Antiviral drug compositions containing lithium inorganic salts |
| 03/30/2000 | CA2278960A1 Spirocyclic c-glycosides |
| 03/29/2000 | EP0988304A1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 03/29/2000 | CN1248976A Protected aminosugars |
| 03/29/2000 | CN1050846C Antitumor antibiotic-Yunan-mycin and preparation process thereof |
| 03/28/2000 | US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy |
| 03/28/2000 | US6043060 Nucleotide analogues |
| 03/28/2000 | US6043059 Performing series of reactions involving hybridizing primer to target and effecting chain extension/chain termination; using primer from presynthesized set having raised annealing temperature and/or improved annealing properties |
| 03/23/2000 | WO2000015203A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor |
| 03/22/2000 | EP0987328A2 Bio-inorganic hybrid composite capable of storing and carrying genes and preparation thereof |
| 03/22/2000 | EP0987024A2 Immunosuppressive agents |
| 03/22/2000 | EP0986570A1 Gemcitabine derivatives |
| 03/22/2000 | CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides |
| 03/21/2000 | US6040439 Method for chemical synthesis of oligonucleotides |
| 03/21/2000 | US6040298 Methods for treatment with compositions effective against acyclovir-resistant strains of herpes viruses |
| 03/16/2000 | WO2000014102A1 Photoresponsive nucleosides and phosphoramidites |
| 03/16/2000 | WO2000014101A1 Pteridine nucleotide analogs |
| 03/16/2000 | WO2000013487A2 Plant fungus inhibiting compounds, process for their preparation, compositions containing them and their use in a method for combatting plant fungi |
| 03/16/2000 | WO1999064047A9 Novel antiviral compounds |
| 03/16/2000 | WO1999063929A9 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/16/2000 | CA2343134A1 Pteridine nucleotide analogs |
| 03/15/2000 | EP0985415A1 Uracil reductase inactivators |
| 03/15/2000 | EP0984976A1 Process for the preparation of a deoxyuridine derivative |
| 03/15/2000 | EP0550580B1 Uracil reductase inactivator |
| 03/14/2000 | CA2282147A1 Immunosuppresive agents |
| 03/09/2000 | WO2000012563A1 Improved process for the synthesis of oligonucleotides incorporating 2-aminoadenosine |
| 03/09/2000 | WO2000012519A1 Phosphoepoxides, method for making same and uses |
| 03/09/2000 | WO2000012516A1 Phosphohalohydrins, method for making same and uses |
| 03/09/2000 | WO2000012098A1 Medicinal compositions for treating eye diseases |
| 03/09/2000 | CA2342204A1 Medicinal compositions for treating eye diseases |
| 03/09/2000 | CA2341578A1 Phosphoepoxides, method for making same and uses |
| 03/08/2000 | EP0984021A2 Synthesis of oligonucleotides |
| 03/08/2000 | EP0984013A2 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane |
| 03/08/2000 | EP0983291A1 Carbamate-derivatized nucleosides and oligonucleosides |
| 03/08/2000 | EP0800527B1 Novel processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 03/07/2000 | US6034087 Nucleoside derivatives and process for preparing thereof |
| 03/07/2000 | CA1340918C Macrolide compounds |
| 03/02/2000 | WO2000011149A1 Methods of producing high titer recombinant adeno-associated virus |
| 03/02/2000 | WO2000011013A1 Modified nucleomonomers and methods of use thereof |
| 03/02/2000 | WO2000011011A1 3'-desoxypentopyranosyl nucleic acid, its production and its use |
| 03/02/2000 | WO1999064054A9 Multibinding inhibitors of topoisomerase |
| 03/02/2000 | WO1999063937A3 Multivalent macrolide antibiotics |
| 03/01/2000 | EP0981534A2 Dinucleotides and their uses |